{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:23:22Z","timestamp":1780442602219,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1710,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/mt.2011.227","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:53:34Z","timestamp":1318953214000},"page":"267-274","source":"Crossref","is-referenced-by-count":34,"title":["Preclinical Dose-Finding Study With a Liver-Tropic, Recombinant AAV-2\/8 Vector in the Mouse Model of Galactosialidosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Huimin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elida","family":"Gomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Allay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"d'Azzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.227_bib1","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/hmg\/9.18.2715","article-title":"Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis","volume":"9","author":"Bonten","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2011.227_bib2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/emboj\/17.6.1588","article-title":"Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein\/cathepsin A","volume":"17","author":"van der Spoel","year":"1998","journal-title":"EMBO J"},{"key":"10.1038\/mt.2011.227_bib3","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3811","article-title":"Galactosialidosis","author":"d'Azzo","year":"2001"},{"key":"10.1038\/mt.2011.227_bib4","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1101\/gad.9.21.2623","article-title":"Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells","volume":"9","author":"Zhou","year":"1995","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2011.227_bib5","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood.V99.9.3169","article-title":"Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells","volume":"99","author":"Leimig","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mt.2011.227_bib6","doi-asserted-by":"crossref","first-page":"14880","DOI":"10.1073\/pnas.95.25.14880","article-title":"Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein\/cathepsin A under control of the colony-stimulating factor-1 receptor promoter","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.227_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1096\/fj.03-0941fje","article-title":"Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis","volume":"18","author":"Bonten","year":"2004","journal-title":"FASEB J"},{"key":"10.1038\/mt.2011.227_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2\/8 vector-mediated gene therapy in murine phenylketonuria","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.227_bib9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease","volume":"8","author":"McEachern","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2011.227_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ymthe.2005.01.011","article-title":"AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease","volume":"11","author":"Passini","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2011.227_bib14","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.227_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.mt.6300004","article-title":"Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery","volume":"15","author":"Broekman","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ymthe.2004.12.022","article-title":"Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models","volume":"11","author":"Davidoff","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib17","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2011.227_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood-2006-03-010181","article-title":"Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates","volume":"109","author":"Nathwani","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2011.227_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2008.08.043","article-title":"Preliminary evaluation of a self-complementary AAV2\/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice","volume":"204","author":"Osman","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1038\/mt.2011.227_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/hmg\/11.12.1455","article-title":"Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice","volume":"11","author":"de Geest","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2011.227_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-1885-3_2","article-title":"The different faces of disease. FACE diagnosis of disease","volume":"376","author":"Klock","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/mt.2011.227_bib23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3302282","article-title":"Transgenic rescue of Krabbe disease in the twitcher mouse","volume":"11","author":"De Gasperi","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.227_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03195698","article-title":"Expression of Npc1 in glial cells corrects sterility in Npc1(-\/-) mice","volume":"50","author":"Donohue","year":"2009","journal-title":"J Appl Genet"},{"key":"10.1038\/mt.2011.227_bib25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2164\/jandrol.107.002980","article-title":"Structural alterations of epididymal epithelial cells in cathepsin A-deficient mice affect the blood-epididymal barrier and lead to altered sperm motility","volume":"28","author":"Hermo","year":"2007","journal-title":"J Androl"},{"key":"10.1038\/mt.2011.227_bib26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2011.227_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2008.10.017","article-title":"Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period","volume":"96","author":"Ogawa","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2011.227_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2008.10.014","article-title":"Age-related efficacy with an AAV vector in Fabry disease mice","volume":"96","author":"Koeberl","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2011.227_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mt.2011.227_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.mt.6300066","article-title":"Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A","volume":"15","author":"Ziegler","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.227_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(88)90999-3","article-title":"Expression of cDNA encoding the human \u201cprotective protein\u201d associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases","volume":"54","author":"Galjart","year":"1988","journal-title":"Cell"},{"key":"10.1038\/mt.2011.227_bib32","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2010.202","article-title":"GMP production of self-complementary serotype 8 AAV vector for a hemophilia B clinical trial","author":"Allay","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.227_bib33","series-title":"Genetic Metabolic Disease: Diagnosis and Prenatal Analysis","author":"Galjaard","year":"1980"},{"key":"10.1038\/mt.2011.227_bib34","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1016\/S0021-9258(18)98751-X","article-title":"Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function","volume":"266","author":"Galjart","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2011.227_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00267823","article-title":"A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes","volume":"100","author":"Schaeren-Wiemers","year":"1993","journal-title":"Histochemistry"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T15:30:54Z","timestamp":1639236654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616304786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1525001616304786"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.227","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}